Exenatide once weekly plus Dapagliflozin once daily versus exenatide or Dapagliflozin alone in patients with type 2 diabetes inadequately controlled with Metformin monotherapy (DURATION-8): a 28 week, multicentre, double-blind, phase 3, randomised controlled trial
doi: 10.1016/j.cmet.2018.03.001
Its common for new patients to occasionally miss a dose due to travel, illness, or forgetfulness
n=283) *Values are Mean SD 14.3 Clinical Studies in Adults with Type 2 Diabetes with Subcutaneous Injections Type 2 Diabetes - Adults (see Table 5) One six-month, open-label, active-controlled study was conducted to compare the safety and efficacy of NOVOLOG to regular human insulin in patients with type 2 diabetes (Table 5)
This is because your dose is relatively small, so the time it takes to inject isn't a problem, and the medicine itself is not thick or viscous, so it easily flows through a smaller needle